An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In

Updated 05/17/2024

Status Terminated

Clinical Trial Summary

This is a Phase 1 trial evaluating the safety and efficacy of crizotinib in patients with tumors except non-small cell lung cancer that are positive for ALK.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01121588
Study type	Interventional
Source	Pfizer
Contact
Status	Terminated
Phase	Phase 1
Start date	March 22, 2011
Completion date	September 7, 2023

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04047290` - A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors	Phase 1
	Active, not recruiting	`NCT04600206` - Existential Distress in Patients With Advanced Cancer and Their Caregivers
	Terminated	`NCT01243762` - A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)	Phase 1
	Completed	`NCT04728334` - A Phase 1 Dose Escalation and Expansion Study of AK117	Phase 1
	Recruiting	`NCT05939687` - Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection	Phase 3
	Recruiting	`NCT06018142` - Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors
	Not yet recruiting	`NCT03903848` - Cancer Survivors Acute Exercise Response 1	N/A
	Recruiting	`NCT05758571` - Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients	Phase 1/Phase 2
	Completed	`NCT04637295` - Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19
	Completed	`NCT04479579` - Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery	Phase 4
	Recruiting	`NCT04230772` - Clinical Outcomes of NOSES Versus Traditional Robotic-assisted Surgery for Patients With Colorectal Cancer	N/A
	Not yet recruiting	`NCT05650385` - A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors	Phase 1
	Completed	`NCT04616846` - Thromboembolic Risk Screening in Patients With Cancer and COVID-19	N/A
	Completed	`NCT04349969` - A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104	Phase 1
	Recruiting	`NCT04721756` - Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging	Early Phase 1